Hematopoietic • Stem Cell
Garuda Therapeutics develops proprietary hematopoietic stem cell therapies that are self-renewing, HLA-compatible, and transgene-free for immediate patient availability.
Medtech • Pulmonary hypertension
Pulnovo Medical develops medical devices for treating pulmonary hypertension and heart failure, with a focus on their PADN technology.
Biopharma • Obesity Treatment
Helicore Biopharma develops glucose-dependent insulinotropic peptide (GIP) antagonist therapies for obesity treatment.
Drug development • Respiratory conditions
Windward Bio is a clinical-stage drug development company focused on creating treatments for severe respiratory conditions, including asthma and COPD, using long-acting monoclonal antibodies and bispecifics.
Biopharmaceutical • Obesity
Verdiva Bio is a clinical-stage biopharmaceutical company developing next-generation oral and injectable treatments for obesity and cardiometabolic disorders.
Biotech • Immunomodulators
Aviceda Therapeutics is a biotech company developing next-generation immunomodulators for ophthalmic conditions using its proprietary HALOSâ„¢ nanotechnology platform.
Biopharmaceutical • Ion Channel Modulators
SiteOne Therapeutics is a biopharmaceutical company developing selective, small molecule ion channel modulators for treating sensory hyperexcitability disorders like pain and chronic cough.
Biotechnology • Clinical-stage
Angitia Biopharmaceuticals is a clinical-stage biotechnology company developing novel treatments for serious musculoskeletal diseases.
Biotechnology • Oncology
Avenzo Therapeutics is a biotechnology company developing oncology therapies, including a CDK2 inhibitor for advanced solid tumors and HR+/HER2-negative metastatic breast cancer.
Biotech • Clinical-stage
Alentis Therapeutics is a biotech company developing antibody-drug conjugates for treating Claudin-1 positive tumors and organ fibrosis.
Biotechnology • Central Nervous System
Leal Therapeutics is a biotechnology company developing treatments for central nervous system disorders, focusing on amyotrophic lateral sclerosis (ALS) and schizophrenia.
Biotech • Antibody treatments
Triveni Bio is a biotech company developing novel antibody treatments for immunological and inflammatory disorders.
Biotechnology • Autoimmune therapies
Candid Therapeutics, Inc. is a biotechnology company developing transformative therapies for autoimmune diseases.
Biotechnology • Immunomodulators
Odyssey Therapeutics is a biotech firm specializing in developing precision immunomodulators and oncology medicines, with plans to advance multiple therapeutic programs into clinical studies.
Healthcare • Lymphedema Treatment
Koya Medical develops innovative treatments for lymphedema and other venous diseases, aiming to provide personalized care for patients suffering from these debilitating conditions.
Biotechnology • Immune Therapies
Forward Therapeutics is a company focused on advancing the development of next-generation small molecule immune therapies.
Biotechnology • Disease Targeting
Terremoto Biosciences is a biotechnology company that has raised $175 million in a Series B financing round to advance its platform and support the development of multiple in-house programs targeting diseases of high unmet medical need.
Biotech • Antibody treatments
Triveni Bio is a biotech company developing novel antibody treatments for immunological and inflammatory disorders.
Biotechnology • Gene Therapy
Rampart Bioscience is a biotechnology company developing next-generation biologics using their proprietary DNA-based medicines platform, HALO, with a focus on treating hypophosphatasia.
Genetic Medicines • MRNA Therapeutics
ReCode Therapeutics is a genetic medicines company that uses precision delivery to develop mRNA and gene correction therapeutics, with a focus on treatments for primary ciliary dyskinesia, cystic fibrosis, and other genetic diseases.
Biopharmaceuticals • Cardiovascular Therapies
Corteria Pharmaceuticals is a biopharmaceutical company that develops first-in-class therapies for unaddressed heart failure subpopulations, with a focus on multi-organ benefits targeting the kidneys, heart, and vessels.
Biotechnology • Antibody Therapies
Star Therapeutics is a biotechnology company that develops first-in-class antibody therapies, primarily for hematology and immunology, and also generates additional biotech companies focused on discovering and advancing novel antibody therapies.
Biotechnology • Gene Editing
Epigenic Therapeutics is a biotechnology company that develops gene editing therapies for various diseases using its proprietary technology platform, EPIREG, which optimizes CRISPR-Cas components for gene regulation without altering DNA sequences and employs a proprietary lipid nanoparticle medicine delivery system.
Precision Oncology • Clinical Development
FORE Biotherapeutics is a precision oncology company that focuses on the clinical development of plixorafenib, a novel small-molecule inhibitor for treating BRAF-altered tumors.